Logos Global Management as of June 30, 2025
Portfolio Holdings for Logos Global Management
Logos Global Management holds 49 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Series Trust S&p Biotech Call Option (XBI) | 9.2 | $83M | 1.0M | 82.93 | |
| Ideaya Biosciences (IDYA) | 7.8 | $70M | 3.3M | 21.02 | |
| Akero Therapeutics (AKRO) | 7.1 | $64M | 1.2M | 53.36 | |
| Revolution Medicines (RVMD) | 6.9 | $63M | 1.7M | 36.79 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.3 | $48M | 450k | 106.12 | |
| Disc Medicine (IRON) | 4.1 | $37M | 700k | 52.96 | |
| Arvinas Ord Call Option (ARVN) | 3.9 | $35M | 4.8M | 7.36 | |
| Janux Therapeutics Call Option (JANX) | 3.8 | $35M | 1.5M | 23.10 | |
| Avidity Biosciences Ord (RNA) | 3.0 | $27M | 950k | 28.40 | |
| Keros Therapeutics (KROS) | 3.0 | $27M | 2.0M | 13.35 | |
| Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA) | 2.8 | $25M | 1.5M | 16.76 | |
| Biogen Idec (BIIB) | 2.8 | $25M | 200k | 125.59 | |
| United Therapeutics Corporation (UTHR) | 2.7 | $24M | 85k | 287.35 | |
| Ocular Therapeutix (OCUL) | 2.3 | $20M | 2.2M | 9.28 | |
| Erasca (ERAS) | 2.1 | $19M | 15M | 1.27 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $19M | 150k | 125.69 | |
| Dyne Therapeutics (DYN) | 2.0 | $18M | 1.9M | 9.52 | |
| Immunocore Hldgs Ads (IMCR) | 2.0 | $18M | 575k | 31.38 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.0 | $18M | 850k | 20.74 | |
| Apellis Pharmaceuticals Call Option (APLS) | 1.9 | $17M | 1.0M | 17.31 | |
| Madrigal Pharmaceuticals (MDGL) | 1.7 | $15M | 50k | 302.64 | |
| Design Therapeutics (DSGN) | 1.6 | $14M | 4.2M | 3.37 | |
| Krystal Biotech (KRYS) | 1.5 | $14M | 100k | 137.46 | |
| Olema Pharmaceuticals (OLMA) | 1.5 | $14M | 3.2M | 4.26 | |
| Celldex Therapeutics Com New (CLDX) | 1.4 | $12M | 600k | 20.35 | |
| Biohaven (BHVN) | 1.1 | $9.9M | 700k | 14.11 | |
| Xencor (XNCR) | 1.1 | $9.8M | 1.3M | 7.86 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.0 | $9.5M | 225k | 42.05 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.0 | $9.4M | 200k | 47.20 | |
| Cidara Therapeutics Com New (CDTX) | 1.0 | $9.3M | 190k | 48.71 | |
| Crescent Biopharma (CBIO) | 1.0 | $8.9M | 554k | 16.14 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.0 | $8.9M | 250k | 35.49 | |
| Rhythm Pharmaceuticals (RYTM) | 0.9 | $8.2M | 130k | 63.19 | |
| Maze Therapeatics (MAZE) | 0.8 | $7.5M | 612k | 12.27 | |
| Larimar Therapeutics Call Option (LRMR) | 0.8 | $7.2M | 2.5M | 2.89 | |
| Enliven Therapeutics (ELVN) | 0.8 | $7.0M | 350k | 20.06 | |
| Jade Biosciences Com New (JBIO) | 0.7 | $6.2M | 625k | 9.99 | |
| Annexon (ANNX) | 0.6 | $5.8M | 2.4M | 2.40 | |
| Mestera (MTSR) | 0.6 | $5.7M | 200k | 28.45 | |
| Trevi Therapeutics (TRVI) | 0.5 | $4.6M | 850k | 5.47 | |
| Immunovant (IMVT) | 0.5 | $4.4M | 275k | 16.00 | |
| Verastem Com New (VSTM) | 0.5 | $4.2M | 1.0M | 4.15 | |
| Astria Therapeutics | 0.4 | $3.8M | 700k | 5.36 | |
| Bicara Therapeutics (BCAX) | 0.4 | $3.7M | 400k | 9.29 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $2.6M | 1.9M | 1.42 | |
| Rapport Therapeutics (RAPP) | 0.3 | $2.4M | 209k | 11.37 | |
| Unicycive Therapeutics Com New (UNCY) | 0.2 | $2.3M | 474k | 4.77 | |
| Septerna (SEPN) | 0.1 | $1.2M | 109k | 10.57 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $18k | 67k | 0.27 |
